Topic: Multiple Sclerosis

MS more active in spring and summer: study

The neurological disease multiple sclerosis can be more active in the spring and summer, according to a new study that detected brain lesions two to three times more frequently in warmer months. "Our results showed that the appearance of lesions on brain ...
Writer J.K. Rowling has donated 10 million pounds to set up a new multiple sclerosis (MS) research clinic, the Harry Potter author revealed on Tuesday. She hopes the clinic, to be based at the University of Edinburgh, will become a world centre ...

J.K. Rowling gives millions for MS research

LONDON (Reuters Life!) - "Harry Potter" author J.K. Rowling has donated 10 million pounds ($15.5 million) to set up a new clinic to carry out research into multiple sclerosis (MS), the disease which killed her mother. The clinic, based at the University ...
'Harry Potter' author JK Rowling donates $15.4 million to multiple sclerosis researchAuthor J.K. Rowling has given $15.4 million to set up a clinic to treat and research multiple sclerosis, the disease that killed her mother. The creator of Harry Potter says she ...
'Harry Potter' author JK Rowling donates 10 million pounds to multiple sclerosis researchAuthor J.K. Rowling has given 10 million pounds ($15.4 million) to set up a clinic to treat and research multiple sclerosis, the disease that killed her mother. The creator of ...
Acorda Therapeutics' 2nd-quarter loss narrows on sales of multiple sclerosis drug AmpyraBiotechnology company Acorda Therapeutics Inc. said Tuesday its second-quarter loss narrowed on a boost in sales of the multiple sclerosis drug Ampyra. The company lost $6.8 million, or 18 cents per ...
Colorado bicyclist injured by cannon blast at charity race; teenagers investigatedA bicyclist riding in a multiple sclerosis fundraiser was bombarded by cannon blast in what authorities suspect was a teenage prank gone awry. The La Plata County Sheriff's office say they plan ...

Merck KGaA expects MS pill to lift drugs margin

FRANKFURT (Reuters) - German pharmaceuticals and chemicals company Merck KGaA is banking on an experimental multiple sclerosis (MS) pill to lift operating margins at its embattled drugs unit, it said on Wednesday. Earnings before interest, tax and special items at its Merck ...